0.682
16.89%
-0.1386
Finanzdaten der Io Biotech Inc-Aktie (IOBT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
28.34%
20.20
|
28.18 | 23.48 | 21.85 | 17.92 |
Operating Income/Loss |
28.34%
-20.20
|
-28.18 | -23.48 | -21.85 | -17.92 |
Nonoperating Income/Loss |
50.93%
1.155
|
2.354 | 1.366 | 1.206 | 1.286 |
Income/Loss From Continuing Operations Before Tax |
26.28%
-19.04
|
-25.83 | -22.12 | -20.65 | -16.64 |
Income Tax Expense/Benefit |
17.56%
0.415
|
0.353 | -0.439 | 0.532 | 0.406 |
Income/Loss From Continuing Operations After Tax |
25.69%
-19.46
|
-26.18 | -21.68 | -21.18 | -17.04 |
Net Income/Loss
|
25.69%
-19.46
|
-26.18 | -21.68 | -21.18 | -17.04 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
775.05%
65.88
|
7.5288 | 50.17 | 28.82 | 28.82 |
Diluted Average Shares |
775.05%
65.88
|
7.5288 | 50.17 | 28.82 | 28.82 |
Basic Earnings Per Share |
6.25%
-0.30
|
-0.32 | -0.43 | -0.74 | -0.59 |
Diluted Earnings Per Share |
6.25%
-0.30
|
-0.32 | -0.43 | -0.74 | -0.59 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):